The healthcare biotech industry of South Korea's competing with several developed countries with investing 20.3 Billion USD In Biotech.
The healthcare biotech industry of South Korea's competing with several developed countries. South Korean government has infused investment into basic as well as applied research. South Korea has also currently started financing procedures to transfer technology from country's excellent educational institutions to private sector.
Current development has also finished in offering a lawful framework to give higher IP (intellectual property) safety to companies & encourages increasing the IP reliable biotech enterprises. Decentralization and better private investment (PI) in the biotech sector is stimulating startup activity.
And now, South Korea is planning to spend 20.3 billion US dollar to improve its standing in the field of biotechnology in the coming 10 years.
According to the Science & Technology Ministry, the biotech plan calls for country's funds to be invested into research & development activities, basically improving infrastructure related to and facilitating technological exchanges worldwide.
South Korean biotechnology firms are also leading the way in creating and participating in transnational collaborative linkages in R&D, investment, licensing partnerships and arrangements. These deals span Asia, North America, Europe and the Middle East. The new invest plan intends to transform the country image into one of the top biotech leaders in the world by the year-end 2016.
Related Market Research Reports:
Asia Pacific Biotechnology Market (2008-2012)
Booming Biotech Market in India
US Biotech Market Analysis
